Banner: BENLYSTA Free Information Kit

Information Kit


Real patient
compensated by GSK

In a clinical study in Black patients with lupus, a reduction in disease activity was seen but was not statistically significant. Ask your doctor about BENLYSTA.


Your Free BENLYSTA Information Kit

Receive tips, tools, treatment information, and facts on living with lupus when you request your free BENLYSTA Information Kit.


What will you get?

Your Information Kit can help you learn more about living with lupus and treatment with BENLYSTA (belimumab). Use these educational resources as you and your doctor consider adding BENLYSTA to your current lupus treatment.

Get Started

Your Information Kit will contain:

  1. Important Facts About BENLYSTA
  2. Information to help you understand how BENLYSTA works
  3. BENLYSTA Cares Information
Icon: More Information

Request Your Information Kit

Simply fill in the form below to request your own Information Kit. We'll send it to you shortly—along with more support and helpful news about BENLYSTA.


Frequently Asked Questions

  • If I have questions about taking BENLYSTA, whom can I talk to?

    You can ask your healthcare provider or pharmacist for information about BENLYSTA. Our nurses* at BENLYSTA Cares can also answer general questions about your treatment and provide you with additional resources to help with your lupus treatment.

    Call 1-877-4-BENLYSTA (1-877-423-6597), 8 am - 8 pm Eastern Time, Monday through Friday.


    *Nurses from BENLYSTA Cares do not give medical advice, and will direct you to your healthcare provider for any disease-, treatment-, or referral-related questions.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • Can I stop taking my other medicines while on BENLYSTA?

    Talk to your doctor. You should not make any changes in your medication regimen without first consulting your doctor. BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.
  • How is BENLYSTA administered?

    For children ages 5 and above and adults, BENLYSTA can be administered by your healthcare provider through an IV infusion

    For adults, BENLYSTA can also be self-injected once a week through a subcutaneous (SC) injection, either with an autoinjector or a prefilled syringe.

    Learn more about dosing for BENLYSTA.

    Was this helpful?

    Yes, it was helpful.
    No, it was not helpful.

See the BENLYSTA experience from their perspective

Real BENLYSTA patients will share their experiences living with lupus and tips for starting BENLYSTA treatment.


What kind of treatment is BENLYSTA?

Find out what makes BENLYSTA a different type of treatment for lupus. Understand how BENLYSTA works and how it can be administered.